Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Joshua AM, Sacco JJ, Shoushtari AN, Orloff M, Piulats JM, Milhem M, Salama AKS, Curti B, Demidov L, Gastaud L, Mauch C, Yushak M, Carvajal RD, Hamid O, Abdullah SE, Holland C, Goodall H, Piperno-Neumann S; IMCgp100-202 Investigators. Nathan P, et al. Among authors: yushak m. N Engl J Med. 2021 Sep 23;385(13):1196-1206. doi: 10.1056/NEJMoa2103485. N Engl J Med. 2021. PMID: 34551229 Free article. Clinical Trial.
Approaches to High-Risk Resected Stage II and III Melanoma.
Yushak M, Mehnert J, Luke J, Poklepovic A. Yushak M, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e207-e211. doi: 10.1200/EDBK_239283. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099653 Free article. Review.
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, Zhong J, Yushak ML, Harvey RD, Paulos CM, Lawson DH, Khan MK, Kudchadkar RR, Buchwald ZS. Qian DC, et al. Among authors: yushak ml. Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12. Lancet Oncol. 2021. PMID: 34780711 Clinical Trial.
Exploring the melanoma survivorship experience: a qualitative study.
Wolner ZJ, Flowers NI, Yushak ML, Chen SC, Yeung H. Wolner ZJ, et al. Among authors: yushak ml. Br J Dermatol. 2021 Jul;185(1):221-223. doi: 10.1111/bjd.19868. Epub 2021 Jun 3. Br J Dermatol. 2021. PMID: 33544884 Free PMC article. No abstract available.
Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report.
Mueller CM, Hojjatie SL, Lawson DH, Jain N, Robinson J, Khan MK, Yushak ML, A Datoo O'Keefe G. Mueller CM, et al. Among authors: yushak ml. Ocul Immunol Inflamm. 2022 Feb 17;30(2):330-337. doi: 10.1080/09273948.2020.1813782. Epub 2020 Oct 6. Ocul Immunol Inflamm. 2022. PMID: 33021420
70 results